According to the Centers for Disease Control and Prevention (CDC), required immunizations for emergency responders include:
--Tetanus and diphtheria toxoid (receipt of primary series, and Td booster within 10 years)
-- Hepatitis B vaccine series for persons who will be performing direct patient care or otherwise expected to have contact with bodily fluids
There is no indication for the following vaccines given the anticipated conditions in the region:
-- Hepatitis A vaccine (low probability of exposure, even under these conditions, in the U.S. ) No transmission from contaminated water has been identified in the U.S. since the 1980's. Hepatitis A outbreaks have not occurred following other hurricanes or floods in other parts of the country, including the devastating hurricanes in Florida last year, and the Midwestern floods of the late 1990s. The gulf region has had few hepatitis A cases in recent years, with less than 10 in the past three months reported from the New Orleans area. Thus, even though the water and sewage systems are damaged or out of operation in many areas along the Gulf Coast, the risk of a hepatitis A epidemic is extremely low. The vaccine will take at least one to two weeks to provide substantial immunity.
-- Typhoid vaccine (low probability of exposure, even under these conditions, in U.S.).
-- Cholera vaccine (low probability of exposure, even under these conditions, in U.S., plus no licensed cholera vaccine available in the U.S.).
-- Meningococcal vaccine (no expectation of increased risk of meningococcal disease among emergency responders).
-- Rabies vaccine series (the full series is required for protection). Persons who are exposed to potentially rabid animals should be evaluated and receive standard post-exposure prophylaxis, as clinically appropriate.
Source: CDC
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.